Published in Proc Natl Acad Sci U S A on September 15, 1993
When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer (2009) 5.86
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet (2012) 3.14
Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer (2011) 2.18
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res (1997) 2.17
Sterigmatocystin biosynthesis in Aspergillus nidulans requires a novel type I polyketide synthase. J Bacteriol (1995) 1.96
Genetics of hepatocellular carcinoma. World J Gastroenterol (2007) 1.64
Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol (2010) 1.64
Non-viral causes of hepatocellular carcinoma. World J Gastroenterol (2010) 1.63
Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A (2004) 1.45
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A (2000) 1.44
In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology (2009) 1.43
The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (2002) 1.41
Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A (1995) 1.41
Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics (2011) 1.39
Cancer burden and trends in the Asian Pacific Rim region. Asian Pac J Cancer Prev (2004) 1.39
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol (1996) 1.35
Mutational properties of the primary aflatoxin B1-DNA adduct. Proc Natl Acad Sci U S A (1996) 1.29
The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer (1996) 1.28
Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol (2006) 1.25
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
Characterization of the polyketide synthase gene (pksL1) required for aflatoxin biosynthesis in Aspergillus parasiticus. J Bacteriol (1995) 1.17
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci (2011) 1.08
Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells. J Virol (1997) 1.08
Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut (2002) 1.04
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer (1999) 0.97
p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect (1996) 0.94
P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers. Environ Health Perspect (1996) 0.94
Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol (2013) 0.93
Codon 249 mutations of p53 gene in non-neoplastic liver tissues. World J Gastroenterol (1999) 0.89
Environmental factors inducing human cancers. Iran J Public Health (2012) 0.89
Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand. Hepat Res Treat (2011) 0.88
A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site. Nucleic Acids Res (1996) 0.88
Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. Carcinogenesis (2014) 0.87
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53. Nat Commun (2015) 0.86
12th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: susceptibility to environmental hazards. Environ Health Perspect (1997) 0.84
Soft tissue sarcomas and p53 mutations. Mol Med (1998) 0.83
Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua. J Biol Chem (2014) 0.82
Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma. World J Gastroenterol (2013) 0.80
Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure? Environ Health Perspect (1997) 0.80
Accurate DNA fragment sizing by capillary electrophoresis with laser-induced fluorescence array for detection of sequence specificity of DNA damage. Anal Chem (2008) 0.80
Low density DNA microarray for detection of most frequent TP53 missense point mutations. BMC Biotechnol (2005) 0.80
Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? Infect Agent Cancer (2012) 0.80
Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ Health Perspect (1997) 0.79
The genetics of human cancer: implications for ecotoxicology. Environ Health Perspect (1994) 0.79
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer. Front Oncol (2015) 0.79
Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma? Diagn Interv Radiol (2015) 0.79
Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Br J Cancer (1995) 0.78
Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma. World J Hepatol (2010) 0.78
Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design. Protein Sci (2014) 0.78
Aflatoxin B1 invokes apoptosis via death receptor pathway in hepatocytes. Oncotarget (2016) 0.77
Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype. Nucleic Acids Res (1997) 0.77
Recessive oncogenes: current status. Pathol Oncol Res (1995) 0.77
Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection. Sci Rep (2016) 0.76
Aflatoxin B1 inhibits the type 1 interferon response pathway via STAT1 suggesting another mechanism of hepatocellular carcinoma. Infect Agent Cancer (2017) 0.75
Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells. PLoS One (2014) 0.75
Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2016) 0.75
Influence of aflatoxin B1 on copy number variants in human leukocytes in vitro. Mol Cytogenet (2015) 0.75
Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care? Am J Clin Oncol (2015) 0.75
AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249. Oncotarget (2017) 0.75
DNA polymerase ζ limits chromosomal damage and promotes cell survival following aflatoxin exposure. Proc Natl Acad Sci U S A (2016) 0.75
Sequential dietary exposure to aflatoxin B1 and fumonisin B1 in F344 rats increases liver preneoplastic changes indicative of a synergistic interaction. Food Chem Toxicol (2016) 0.75
p53 mutations in human cancers. Science (1991) 31.96
Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides. Biochemistry (1983) 6.68
Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (1991) 6.16
Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet (1986) 6.07
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (1991) 6.04
High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus. Gene (1991) 5.65
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80
Characterization of the human p53 gene. Mol Cell Biol (1986) 4.33
High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase. Nucleic Acids Res (1990) 4.12
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer (1992) 3.50
Base substitution mutations induced by metabolically activated aflatoxin B1. Proc Natl Acad Sci U S A (1983) 2.48
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res (1991) 1.89
In vitro reactions of aflatoxin B1-adducted DNA. Proc Natl Acad Sci U S A (1981) 1.73
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer (1985) 1.54
p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res (1992) 1.44
Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis (1993) 1.30
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res (1991) 1.30
Sequence specificity in aflatoxin B1--DNA interactions. Proc Natl Acad Sci U S A (1983) 1.28
Kinds of mutations formed when a shuttle vector containing adducts of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9, 10-tetrahydrobenzo[a]pyrene replicates in human cells. Proc Natl Acad Sci U S A (1987) 1.25
p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res (1992) 1.23
Spontaneous reactions of aflatoxin B1 modified deoxyribonucleic acid in vitro. Biochemistry (1980) 1.23
Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res (1992) 1.19
Mechanisms of mutagenesis by a bulky DNA lesion at the guanine N7 position. Genetics (1988) 1.18
Excision repair of aflatoxin B1-DNA adducts in human fibroblasts. Cancer Res (1981) 1.04
p53 Mutations in human hepatocellular carcinomas from Germany. Cancer Res (1992) 1.04
A genotypic mutation system measuring mutations in restriction recognition sequences. Nucleic Acids Res (1991) 1.03
Formation and removal of aflatoxin B1-induced DNA lesions in epithelioid human lung cells. Cancer Res (1979) 1.01
Genotypic mutation analysis by RFLP/PCR. Mutat Res (1993) 0.99
Markers of exposure to carcinogens. Environ Health Perspect (1989) 0.88
Effect of formation and removal of aflatoxin B1:DNA adducts in 10T 1/2 mouse embryo fibroblasts on cell viability. Cancer Res (1980) 0.88
Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by Taq I restriction fragment length polymorphism/polymerase chain reaction in the c-H-ras1 gene. Proc Natl Acad Sci U S A (1992) 0.86
Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci U S A (1994) 2.64
Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst (1999) 2.10
The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol (1995) 2.05
Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol (1999) 1.62
p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med (1998) 1.55
Geographic variation of p53 mutational profile in nonmalignant human liver. Science (1994) 1.51
The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry (1991) 1.32
Rapid detection of influenza virus H1 by the polymerase chain reaction. Biochem Biophys Res Commun (1990) 1.26
Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res (1995) 1.23
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes (1996) 1.23
Spontaneous reactions of aflatoxin B1 modified deoxyribonucleic acid in vitro. Biochemistry (1980) 1.23
Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res (1991) 1.20
Selective reduction of yeast transfer ribonucleic acid with sodium borohydride. J Mol Biol (1967) 1.19
Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J (1997) 1.16
Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts. Proc Natl Acad Sci U S A (1984) 1.13
Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J Biol Chem (1994) 1.08
Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells. Carcinogenesis (1988) 1.07
A genotypic mutation system measuring mutations in restriction recognition sequences. Nucleic Acids Res (1991) 1.03
Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene (1994) 1.03
Apyrimidinic sites in gamma-irradiated DNA. FEBS Lett (1975) 1.02
Poly(ADP-ribosylation) of histones in intact human keratinocytes. Biochemistry (1989) 1.02
Structure of the photohydration products of cytidine and uridine. Proc Natl Acad Sci U S A (1968) 1.01
Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines. Int J Cancer (1996) 1.00
Interaction of partially reduced polyuridylic acid with polyadenylic acid. Biochem Biophys Res Commun (1966) 1.00
Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. J Natl Cancer Inst (2001) 0.99
Genotypic mutation analysis by RFLP/PCR. Mutat Res (1993) 0.99
Transfection with human copper-zinc superoxide dismutase induces bidirectional alterations in other antioxidant enzymes, proteins, growth factor response, and paraquat resistance. Free Radic Biol Med (1995) 0.98
Calcium chelator Quin 2 prevents hydrogen-peroxide-induced DNA breakage and cytotoxicity. Eur J Biochem (1989) 0.98
Detection and determination of 5,6-dihydrouridine and 4-thiouridine in transfer ribonucleic acid from different sources. J Mol Biol (1968) 0.95
Continuous production of Rous sarcoma virus free of transformation defective virus in clones of established RSV-transformed quail cells. Virology (1981) 0.93
Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Int J Cancer (1996) 0.93
Genetic modulation of the cellular antioxidant defense capacity. Environ Health Perspect (1990) 0.91
Clastogenic activity from Bloom syndrome fibroblast cultures. Proc Natl Acad Sci U S A (1981) 0.91
Suppression of tumor promoter phorbolmyristate acetate-induced chromosome breakage by antioxidants and inhibitors of arachidonic acid metabolism. Mutat Res (1983) 0.91
Tumor promoter phorbol-12-myristate-13-acetate induces poly(ADP)-ribosylation in fibroblasts. EMBO J (1985) 0.91
Formation and excision of covalent deoxyribonucleic acid adducts of benzo[a]pyrene 4,5-epoxide and benzo[a]pyrenediol epoxide I in human lung cells A549. Biochemistry (1980) 0.91
Photoreduction of uridine and reduction of dihydrouridine with sodium borohydride. J Am Chem Soc (1968) 0.89
UVB-induced DNA breaks interfere with transcriptional induction of c-fos. Mol Cell Biol (1993) 0.88
Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). Hum Mutat (1993) 0.88
Template activity of uridylic acid-dihydrouridylic acid copolymers. Proc Natl Acad Sci U S A (1966) 0.88
ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6. Biochemistry (1989) 0.87
Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. Bull Cancer (1990) 0.87
Excisability and persistence of benzo(a)pyrene DNA adducts in epithelioid human lung cells. Nature (1978) 0.87
Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants. Cancer Res (1989) 0.87
Tumor promoter phorbol-12-myristate-13-acetate induces poly ADP-ribosylation in human monocytes. Biochem Biophys Res Commun (1985) 0.86
The induction of ornithine decarboxylase by phorbol 12-myristate 13-acetate or by serum is inhibited by antioxidants. Carcinogenesis (1983) 0.86
N-Acetoxy-acetylaminofluorene reacts preferentially with a control region of intracellular SV40 chromosome. Nature (1981) 0.86
Distribution and function of cytoskeletal proteins in lung cells with particular reference to 'contractile interstitial cells'. Methods Achiev Exp Pathol (1979) 0.85
Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes. J Immunol (1987) 0.85
Cancer-prone oxyradical overload disease. IARC Sci Publ (1999) 0.85
Oxidants induce phosphorylation of ribosomal protein S6. J Biol Chem (1988) 0.83
Mutagenesis of codon 248 of the human p53 tumor suppressor gene by N-ethyl-N-nitrosourea. Oncogene (1994) 0.83
Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes. Carcinogenesis (1984) 0.82
Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-kappaB. Adv Exp Med Biol (1996) 0.82
p16INK4 mutations and altered expression in human tumors and cell lines. Cold Spring Harb Symp Quant Biol (1994) 0.82
Poly ADP-ribosylation of histones in tumor promoter phorbol-12-myristate-13-acetate treated mouse embryo fibroblasts C3H10T1/2. Biochem Biophys Res Commun (1985) 0.82
Clastogenic action of tumor promoter phorbol-12-myristate-13 acetate in mixed human leukocyte cultures. Carcinogenesis (1983) 0.82
Fat embolism syndrome. Orthop Rev (1993) 0.82
A mammalian mutation system avoiding phenotypic selection: the RFLP/PCR approach. Prog Clin Biol Res (1990) 0.81
Selective photoreduction of nucleotides and nucleic acids. II. Mechanism of the two-step reduction of thymidine. J Am Chem Soc (1966) 0.81
Hydrogen peroxide insult in cultured mammalian cells: relationships between DNA single-strand breakage, poly(ADP-ribose) metabolism and cell killing. Biochim Biophys Acta (1989) 0.81
In vitro reaction of radioactive 7beta, 8alpha, --dihydroxy--9alpha, 10alpha-epoxy--7,8,9,10--tetrahydrobenzo (A) pyrene and 7beta,8alpha--dihydroxy--9beta, 10beta--epoxy--7,8,9,10--tetrahydrobenzo (A) pyrene with DNA. Biochem Biophys Res Commun (1977) 0.81
Quantitative determination of gamma-globulin in the human sera by column chromatography. Anal Biochem (1968) 0.81
Photoreductions and photocyclizations of tryptophan. J Am Chem Soc (1966) 0.80
Gene expression rather than the initiation of DNA replication is the principal target of lethal u.v.-induced damage in a regulatory region of SV40 DNA. Carcinogenesis (1987) 0.80
Phorbol ester-induced formation of clastogenic factor from human monocytes. Carcinogenesis (1987) 0.79
Effects of metabolite VIII of bromexine (Na 872) on type II epithelium of the lung: an experimental and morphological study with reference to surfactant secretion. Respiration (1979) 0.79
DNA binding of aflatoxin B1 by co-oxygenation in mouse embryo fibroblasts C3H/10T1/2. Biochem Biophys Res Commun (1983) 0.78
Inhibitory effects of nitric oxide and nitrosative stress on dopamine-beta-hydroxylase. J Biol Chem (2000) 0.78
Quantitative determination of gamma-globulin in human sera by column chromatography. Anal Biochem (1968) 0.78
Cytidine photohydration in R17 RNA. J Mol Biol (1972) 0.78
Enhanced formation of benzo(a)pyrene:DNA adducts in monocytes of patients with a presumed predisposition to lung cancer. Cancer Res (1985) 0.77
Ultraviolet B light-induced mutagenesis of p53 hotspot codons 248 and 249 in human skin fibroblasts. Mol Carcinog (1994) 0.77
An immunohistochemical study of the gut neuroendocrine system in juvenile pejerrey Odontesthes bonariensis (Valenciennes). J Fish Biol (2011) 0.77
Antioxidant enzymes in xeroderma pigmentosum fibroblasts. Cancer Res (1988) 0.77
The effect of the selective reduction of yeast transfer ribonucleic acid with sodium borohydride on the acceptance of valine and serine. Biochem Biophys Res Commun (1968) 0.77
Chemopreventive action of mace (Myristica fragrans, Houtt) on DMBA-induced papillomagenesis in the skin of mice. Cancer Lett (1991) 0.76
In vitro transformation of human skin epithelial cells: Role of RAS oncogene in malignant progression. Toxicol In Vitro (1990) 0.76
Non-histone chromosomal protein acceptors for poly(ADP)-ribose in phorbol-12-myristate-13-acetate treated mouse embryo fibroblasts (C3H10T1/2). Carcinogenesis (1985) 0.75
Modulation of methylcholanthrene-induced carcinogenesis in the uterine cervix of mouse by indomethacin. Cancer Lett (1988) 0.75
The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production. Blood Coagul Fibrinolysis (1995) 0.75
Repair of DNA damage induced by ionizing radiation and benzo[a]pyrene in mammalian cells. J Toxicol Environ Health (1977) 0.75
[Psychological, behavioral and occupational status changes after an aortocoronary bypass intervention]. G Ital Cardiol (1995) 0.75
Infectivity of vesicles prepared from chilo iridescent virus inner membrane: evidence for recombination between associated DNA fragments. Virus Res (1989) 0.75
[Eosinophilic granuloma- histiocytosis X]. G Ital Dermatol Minerva Dermatol (1968) 0.75
Near-ultraviolet sensitivity of skin fibroblasts of patients with Bloom's syndrome. Biochem Biophys Res Commun (1981) 0.75
Oxidants and antioxidants in carcinogenesis. Food Addit Contam (1990) 0.75
Chemoprevention of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in rat by the combined actions of selenium, magnesium, ascorbic acid and retinyl acetate. Jpn J Cancer Res (1990) 0.75
Mutagenesis of H-ras codons 11 and 12 in human fibroblasts by N-ethyl-N-nitrosourea. Carcinogenesis (1993) 0.75
Modulatory influences of tamoxifen, tocopherol, retinyl acetate, aminoglutethimide, ergocryptine and selenium on DMBA-induced initiation of mammary carcinogenesis in rats. Indian J Exp Biol (1990) 0.75
[On benign senile pemphigus (pemphigoid or parapemphigus)]. G Ital Dermatol Minerva Dermatol (1966) 0.75
[Photoreactions with iminium salts with methanol and with formamide]. Helv Chim Acta (1967) 0.75
[Giovanni Santoianni (1898-1970)]. G Ital Dermatol Minerva Dermatol (1971) 0.75
[Fragments of linear unintegrated Rous sarcoma virus DNA, resulting from digestion with SmaI restriction endonuclease]. C R Seances Acad Sci D (1979) 0.75
Morphological changes in the mink area postrema during growth and under different stages of sexual activity. Histol Histopathol (2002) 0.75
Modulation of 7,12-dimethylbenz[a]anthracene-induced transmammary carcinogenesis by disulfiram and butylated hydroxyanisole in mice. Jpn J Cancer Res (1989) 0.75
Effects of tert-butyl hydroperoxide on promotable and non-promotable JB6 mouse epidermal cells. Chem Biol Interact (1989) 0.75
Application of quantitative chromatographic technique in the determination of CSF gamma globulin to MS. Int Arch Allergy Appl Immunol (1969) 0.75
[Therapy of male sterility]. Minerva Dermatol (1967) 0.75